SEEK

Developing vaccines that get ahead of pathogenic mutations and protect against the next coronavirus pandemic is one of the aims of the new Oxford, UK-based vaccine development company, ConserV Biosci

Speaking after unveiling positive Phase IIb data on the universal flu vaccine candidate FLU-v, Trevor Phillips, executive chairman of UK firm hVIVO, told Scrip the company expects to begin partnerin

Infirst Healthcare Ltd. lags behind its expectations for introducing reformulated OTC drugs but is right where it wants to be with the UK launch of a cocoa extract-containing cough syrup and the pla

Infirst Healthcare Ltd. lags behind its expectations for introducing reformulated OTC drugs but is right where it wants to be with the UK launch of a cocoa extract-containing cough syrup and the pla